ser 109
seres therapeutics
['ser-109 ']
oral ser-109 effectively prevents c difficile recurrences in open-label study #acg2022
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more